Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-22-013882
Filing Date
2022-04-07
Accepted
2022-04-07 17:15:17
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A pstv-defa14a_20220407.htm DEFA14A 15130
2 GRAPHIC glwwrtf2k3b5000001.jpg GRAPHIC 768834
3 GRAPHIC glwwrtf2k3b5000002.jpg GRAPHIC 470905
  Complete submission text file 0001564590-22-013882.txt   1723778
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 737.255.7194
PLUS THERAPEUTICS, INC. (Filer) CIK: 0001095981 (see all company filings)

EIN.: 330827593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-34375 | Film No.: 22814642
SIC: 3841 Surgical & Medical Instruments & Apparatus